Dose-Finding Based on Feasibility and Toxicity in T-cell Infusion Trials-Reference-Cited by-同舟云学术

Dose-Finding Based on Feasibility and Toxicity in T-cell Infusion Trials

Published:2001-09 Issue:3 Volume:57 Page:914-921
ISSN:0006-341X
Container-title:Biometrics
language:en
Short-container-title:

Author:

Thall Peter F.,Sung Hsi-Guang,Choudhury Aniruddha

Publisher

Wiley

Subject

Applied Mathematics,General Agricultural and Biological Sciences,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Statistics and Probability

Reference21 articles.

1. An evaluation of phase I cancer clinical trial designs;Ahn;Statistics in Medicine,1998

2. Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant;Alyea;Blood,1998

3. Cancer phase I clinical trials: Efficient dose escalation with overdose control;Babb;Statistics in Medicine,1998

4. Approaches for optimal sequential decision analysis in clinical trials;Carlin;Biometrics,1998

5. Specific adoptive immunotherapy of established leukemia with synergistic lymphocytes sequentially immunized in vivo and in vitro and non-specifically expanded by culture with interleuken-2;Cheever;Journal of Immunology,1981

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-finding based on feasibility and late-onset toxicity in adoptive cell therapy trials;Journal of Biopharmaceutical Statistics;2023-03-06

2. Impact of dose feasibility on the conduct of phase I trials of adoptive cell therapy;Contemporary Clinical Trials Communications;2022-02

3. Adaptive dose-finding based on safety and feasibility in early-phase clinical trials of adoptive cell immunotherapy;Clinical Trials;2019-12-19

4. Designs Considering Toxicity and Efficacy;Dose-Finding Designs for Early-Phase Cancer Clinical Trials;2019

5. Adaptive clinical trial designs for phase I cancer studies;Statistics Surveys;2014-01-01